Special considerations in the approach to asthma in infancy and early childhood.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000336:Aerosols; D000393:Air Pollutants / Q000009:adverse effects; D000485:Allergens; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D001985:Bronchial Provocation Tests; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004205:Cromolyn Sodium / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005260:Female; D005764:Gastroesophageal Reflux / Q000150:complications; D006801:Humans; D007223:Infant; D008297:Male; D010276:Parasympatholytics / Q000627:therapeutic use; D012136:Respiratory Syncytial Viruses; D010253:Respirovirus Infections / Q000150:complications; D013806:Theophylline / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D000336:Aerosols; D000393:Air Pollutants; D000485:Allergens; D001993:Bronchodilator Agents; D010276:Parasympatholytics; D013806:Theophylline; D004205:Cromolyn Sodium